Skip to main content
MedPathMedPath Home
Clinical Trials/NCT05793034
NCT05793034
Recruiting
Not Applicable

Analysis of Predictive Factors for Overall and Progression-free Survival After Neurosurgery for Atypical or Anaplastic Meningioma

Fondazione Policlinico Universitario Agostino Gemelli IRCCS1 site in 1 country250 target enrollmentJanuary 7, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMeningiomaMeningioma AtypicalAnaplastic Meningioma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Meningioma
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Enrollment
250
Locations
1
Primary Endpoint
Recurrence-free survival (RFS)
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The investigators plan to collect clinical and molecular data, including ICH, PCR, NGS and methylome, from patients operated on for grade 2 or grade 3 meningioma. The purpose of the study is to identify reliable and easy-to-assess predictive factors for recurrence and survival after surgery.

Registry
clinicaltrials.gov
Start Date
January 7, 2021
End Date
January 7, 2027
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Patient operated for atypical (grade 2) meningioma; or
  • •Patient operated for anaplastic (grade 3) meningioma;
  • •Timeframe for surgery, 1999-2019
  • •Exclusion criteria
  • •Patient lost at follow-up

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Recurrence-free survival (RFS)

Time Frame: 5 years on average

Correlation from biomolecular data and RFS

Secondary Outcomes

  • Overall survival (OS)(5 years on average)

Study Sites (1)

Loading locations...

Similar Trials

Unknown
Not Applicable
Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and Relapse in Myelodysplastic SyndromeMyelodysplastic Syndrome
NCT02330692Yonsei University1,000
Terminated
Not Applicable
Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell CarcinomaCarcinoma, Squamous CellCarcinoma, SquamousSquamous Cell CarcinomaLung NeoplasmsCancer of LungCancer of the LungLung CancerNeoplasms, LungNeoplasms, PulmonaryPulmonary CancerPulmonary Neoplasms
NCT02549638Mayo Clinic22
Completed
Not Applicable
Predictive Gene Profiles and Dynamic Measurement of Treatment Response in Metastatic Non-small Cell Lung CancerMetastatic Nonsmall Cell Lung Cancer
NCT03512847Zealand University Hospital150
Terminated
Not Applicable
Biomarkers for Dexamethasone Response in Sars-Cov-2 / COVID-19 PneumoniaPneumonia, ViralSARS-Cov-2
NCT04619693University Hospital, Montpellier79
Unknown
Not Applicable
Prognostic Biomarker for CRCColorectal Cancer
NCT03928652Sixth Affiliated Hospital, Sun Yat-sen University1,050